Prophylaxis for Pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study

INTRODUCTION: Pneumocystis pneumonia (PCP) is one of the most prevalent opportunistic infections in patients undergoing immunosuppressive therapy. In this article, we discuss risk factors for PCP development in patients with rheumatoid arthritis (RA) during the course of biologic therapy and describ...

Descripción completa

Detalles Bibliográficos
Autores principales: Katsuyama, Takayuki, Saito, Kazuyoshi, Kubo, Satoshi, Nawata, Masao, Tanaka, Yoshiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978920/
https://www.ncbi.nlm.nih.gov/pubmed/24495443
http://dx.doi.org/10.1186/ar4472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978920/
https://www.ncbi.nlm.nih.gov/pubmed/24495443
http://dx.doi.org/10.1186/ar4472

Ejemplares similares